Everest Medicines Acquires Exclusive Greater China and Other Asian Country Rights to VIS-101, a Novel Bifunctional Biologic for Serious Eye Disorders
Oct 30, 2025 17:48 JST
Everest Medicines (HKEX:1952.HK) today announced that it has acquired an exclusive license with Visara, Inc. ("Visara")